The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
Level | Code | Title | |
---|---|---|---|
1 | N | Nervous system | |
2 | N02 | Analgesics | |
3 | N02B | Other analgesics and antipyretics | |
4 | N02BA | Salicylic acid and derivatives |
Code | Title | |
---|---|---|
N02BA01 | Acetylsalicylic acid | |
N02BA02 | Aloxiprin | |
N02BA03 | Choline salicylate | |
N02BA04 | Sodium salicylate | |
N02BA05 | Salicylamide | |
N02BA06 | Salsalate | |
N02BA07 | Ethenzamide | |
N02BA08 | Morpholine salicylate | |
N02BA09 | Dipyrocetyl | |
N02BA10 | Benorilate | |
N02BA11 | Diflunisal | |
N02BA12 | Potassium salicylate | |
N02BA14 | Guacetisal | |
N02BA15 | Carbasalate calcium | |
N02BA16 | Imidazole salicylate | |
N02BA51 | Acetylsalicylic acid, combinations excl. psycholeptics | |
N02BA55 | Salicylamide, combinations excl. psycholeptics | |
N02BA57 | Ethenzamide, combinations excl. psycholeptics | |
N02BA59 | Dipyrocetyl, combinations excl. psycholeptics | |
N02BA65 | Carbasalate calcium combinations excl. psycholeptics | |
N02BA67 | ||
N02BA71 | Acetylsalicylic acid, combinations with psycholeptics | |
N02BA75 | Salicylamide, combinations with psycholeptics | |
N02BA77 | Ethenzamide, combinations with psycholeptics | |
N02BA79 | Dipyrocetyl, combinations with psycholeptics |
Active Ingredient | Description | |
---|---|---|
Acetylsalicylic acid |
Acetylsalicylic acid combines significant advantages such as strong anti-pyretic, analgesic and anti-inflammatory action, that is the measure of comparison with all the newer NSAIDs. |
|
Carbasalate calcium |
Carbasalate calcium is a complex of calcium acetyl salicylic acid and urea. It is a thrombocyte aggregation inhibitor. The antithrombotic effect is due to the irreversible acetylating of the enzyme cyclo-oxygenase in the thrombocyte, through which the formation of the prostaglandin thromboxane A2 is inhibited. |
|
Choline salicylate |
Choline salicylate is an anti-inflammatory and antipyretic medication. It is often used in oral gel form for the relief of pain, discomfort, and inflammation caused by common mouth ulcers, cold sores, denture and sore spots, as well as mouth ulcers, and sore spots because of orthodontic devices. |
|
Diflunisal |
Diflunisal is a difluorophenyl derivate of salicylic acid and a nonsteroidal anti-inflammatory drug (NSAID) with antipyretic, analgesic and anti-inflammatory properties. Diflunisal is a prostaglandin synthetase inhibitor. Diflunisal competitively inhibits both cyclooxygenase (COX) -1 and -2, with higher affinity for COX-1, and subsequently blocks the conversion of arachidonic acid to prostaglandin precursors. This leads to an inhibition of the formation of prostaglandins that are involved in pain, inflammation and fever. Diflunisal differs from other salicylates, in that it is not metabolized to salicylic acid, hence it has a longer half-life. |
|
Ethenzamide |
|
|
Salicylamide |
|
Title | Information Source | Document Type | |
---|---|---|---|
ALKA-SELTZER Effervescent tablet | Health Products Regulatory Authority (IE) | MPI, EU: SmPC | |
ANADIN Original Tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
ASA Delayed-release tablet | Health Products and Food Branch (CA) | MPI, CA: SPM | |
ASPIRIN Gastro-resistant tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
ASPIRIN Tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
ASPIRIN Tablets BP 300mg | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
AUDAX Ear drops, solution | Health Products Regulatory Authority (IE) | MPI, EU: SmPC | |
DISPRIN Dispersible tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |